Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
314 participants
INTERVENTIONAL
2021-07-15
2024-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liquid Formulation Applied by Pen for Ovulation Induction and In-vitro Fertilization
NCT01183143
Follicular Flushing Outcomes in Singles Versus Double Lumen Oocyte Retrieval Needles in Poor Responding Patients
NCT02391155
Effect Of Intravenous IntralipidTherapyon Pregnancy Outcome in Women With History of Recurrent Implantation Failure Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer Cycle: A Randomized Controlled Trial
NCT03374163
A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction
NCT00230815
Aurora Test for Patients Treated With Recombinant Gonadotropins
NCT04710264
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Device: FemaSeed Localized Directional Insemination
FemaSeed (Intratubal Insemination - K231730)
FemaSeed Localized Directional Insemination
Subjects undergoing FemaSeed Artificial Insemination
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FemaSeed Localized Directional Insemination
Subjects undergoing FemaSeed Artificial Insemination
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Current or recent (within the last 3 months) pelvic infection (cervix, endometrium, or fallopian tubes)
3. Prior history of ectopic pregnancy or tubal surgery
19 Years
40 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Femasys Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Elite IVF, PLLC
Mobile, Alabama, United States
Reproductive Associates of Delaware (RAD Fertility)
Newark, Delaware, United States
Women's Medical Research Group, LLC
Clearwater, Florida, United States
Rosemark Women Care Specialists
Idaho Falls, Idaho, United States
Saginaw Valley Medical Research Group
Saginaw, Michigan, United States
The Fertility Center of Las Vegas
Las Vegas, Nevada, United States
Red Rock Fertility Center
Las Vegas, Nevada, United States
Reach Fertility
Charlotte, North Carolina, United States
Carolina Conceptions
Raleigh, North Carolina, United States
Institute for Reproductive Health
Cincinnati, Ohio, United States
University of Cincinnati Physicians
Cincinnati, Ohio, United States
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
Main Line Fertility
Bryn Mawr, Pennsylvania, United States
University of Pennsylvania (Pennsylvania Fertility Care)
Philadelphia, Pennsylvania, United States
LinQ Research
Sugar Land, Texas, United States
Center of Reproductive Medicine
Webster, Texas, United States
Utah Center for Reproductive Medicine
Salt Lake City, Utah, United States
University of Wisconsin, Generations Fertility Care
Middleton, Wisconsin, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CP-200-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.